Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 839 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 476.47 USD | -2.31% | -4.65% | -10.02% | +12.48% | 11.01 B USD | ||
| 860 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.88 USD | -0.58% | -6.09% | -13.99% | -0.92% | 10.62 B USD | ||
| 863 | IBRX ImmunityBio, Inc. - Common Stock | 9.92 USD | +1.74% | +6.90% | +21.57% | +295.22% | 10.51 B USD | ||
| 898 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.83 USD | +1.12% | +4.80% | +1.86% | +98.81% | 10.03 B USD | ||
| 904 | KRYS Krystal Biotech, Inc. - Common Stock | 327.02 USD | +0.75% | +0.53% | -6.26% | +74.76% | 9.68 B USD | ||
| 910 | PCVX Vaxcyte, Inc. - Common Stock | 65.01 USD | -2.91% | +15.99% | +8.37% | +53.69% | 9.67 B USD | ||
| 937 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 139.97 USD | -0.67% | +0.64% | -4.16% | +86.30% | 9.06 B USD | ||
| 952 | KYMR Kymera Therapeutics, Inc. - Common Stock | 109.34 USD | +0.91% | -0.71% | -5.20% | +85.01% | 9.09 B USD | ||
| 960 | AXSM Axsome Therapeutics, Inc. - Common Stock | 170.08 USD | -1.67% | -6.59% | -18.22% | +30.63% | 8.91 B USD | ||
| 973 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 60.70 USD | -1.27% | -6.31% | -28.29% | +55.24% | 8.57 B USD | ||
| 975 | CYTK Cytokinetics, Incorporated - Common Stock | 62.03 USD | +1.49% | -5.47% | -16.53% | +6.76% | 8.62 B USD | ||
| 996 | TGTX TG Therapeutics, Inc. - Common Stock | 53.34 USD | +0.74% | -0.52% | -3.98% | +48.99% | 8.16 B USD | ||
| 1049 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 263.38 USD | -5.27% | -8.20% | -25.35% | +387.92% | 7.35 B USD | ||
| 1054 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 43.31 USD | -1.92% | -1.57% | -23.02% | -39.95% | 7.20 B USD | ||
| 1072 | SYRE Spyre Therapeutics, Inc. - Common Stock | 79.92 USD | -1.15% | -11.13% | -9.25% | +234.25% | 7.05 B USD | ||
| 1098 | ABVX Abivax SA - American Depositary Shares | 89.01 USD | +2.30% | -6.40% | -24.69% | +2.18% | 6.99 B USD | ||
| 1141 | IMVT Immunovant, Inc. - Common Stock | 30.25 USD | -5.59% | -10.10% | -22.65% | +57.47% | 6.25 B USD | ||
| 1149 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.64 USD | +1.35% | -4.14% | -10.63% | -18.74% | 6.17 B USD | ||
| 1167 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 13.33 USD | +3.17% | -6.32% | +53.93% | +489.82% | 6.04 B USD | ||
| 1169 | BLTE Belite Bio Inc - American Depositary Shares | 152.37 USD | -2.38% | -6.51% | -20.26% | +95.02% | 5.99 B USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |